Rachel Kornfield1, G Caleb Alexander2, Dima M Qato3, Yoonsang Kim4, Jan D Hirsch5, Sherry L Emery4. 1. School of Journalism and Mass Communication, University of Wisconsin-Madison, Madison, Wisconsin. Electronic address: rkornfield@wisc.edu. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Center for Drug Safety and Effectiveness, Johns Hopkins University; Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, Maryland. 3. Department of Pharmacy Systems, Outcomes and Policy; Center for Pharmacoepidemiology and Pharmacoeconomic Research. 4. Health Media Collaboratory, Institute for Health Research and Policy, University of Illinois, Chicago, Illinois. 5. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla; Department of Veterans Affairs of San Diego Healthcare System, San Diego, California.
Abstract
INTRODUCTION: TV accounts for more than half of pharmaceutical direct-to-consumer advertising (DTCA) spending in the U.S. The purpose of this study is to quantify average household exposure to branded and non-branded (help-seeking) televised prescription drug advertisements and describe variation over time and according to medication indication and geography. METHODS: In 2013, Nielsen TV ratings were compiled for prescription pharmaceutical advertising that aired between 2003 and 2011 for the top 75 U.S. media markets. All advertisements were coded as branded or help-seeking. Advertisements were further coded for one of eight prevalent indications (allergies, arthritis, asthma, erectile dysfunction, high cholesterol, smoking cessation, depression, and sleep disorder) or as "other." RESULTS: Televised DTCA exposure increased from 2003 to 2007 and then declined 43% by 2011, to 111 monthly prescription drug advertisements per household. The examined indications were associated with varying amounts and patterns of exposure, with greatest declines among medications for allergies and sleep disorders. Help-seeking advertisements comprised 10% of total exposure, with substantial variation by indication. CONCLUSIONS: Considerations of DTCA's effects on health care should take into account the shifting concentration of advertising across indications.
INTRODUCTION: TV accounts for more than half of pharmaceutical direct-to-consumer advertising (DTCA) spending in the U.S. The purpose of this study is to quantify average household exposure to branded and non-branded (help-seeking) televised prescription drug advertisements and describe variation over time and according to medication indication and geography. METHODS: In 2013, Nielsen TV ratings were compiled for prescription pharmaceutical advertising that aired between 2003 and 2011 for the top 75 U.S. media markets. All advertisements were coded as branded or help-seeking. Advertisements were further coded for one of eight prevalent indications (allergies, arthritis, asthma, erectile dysfunction, high cholesterol, smoking cessation, depression, and sleep disorder) or as "other." RESULTS: Televised DTCA exposure increased from 2003 to 2007 and then declined 43% by 2011, to 111 monthly prescription drug advertisements per household. The examined indications were associated with varying amounts and patterns of exposure, with greatest declines among medications for allergies and sleep disorders. Help-seeking advertisements comprised 10% of total exposure, with substantial variation by indication. CONCLUSIONS: Considerations of DTCA's effects on health care should take into account the shifting concentration of advertising across indications.
Authors: David T Levy; K Michael Cummings; Andrea C Villanti; Ray Niaura; David B Abrams; Geoffrey T Fong; Ron Borland Journal: Addiction Date: 2016-04-25 Impact factor: 6.526
Authors: Helen W Sullivan; Amie C O'Donoghue; Molly Lynch; Mihaela Johnson; Christine Davis; Douglas J Rupert Journal: Med Decis Making Date: 2019-10-04 Impact factor: 2.583